pharma · Glaucoma · Macular Edema
Allergan Pharmaceuticals International
Allergan Pharmaceuticals International Limited
Allergan Pharmaceuticals International clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Dublin, IE
- Programs
- 13
- Drugs
- 15
- Patents
- 25
Allergan Pharmaceuticals International projects
5 ClinicalTrials.gov programs sponsored by Allergan Pharmaceuticals International.
Allergan Pharmaceuticals International has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AGN 211745
Allergan Pharmaceuticals International Limited
Choroid Neovascularization
1 trial -
Brimo PS DDS®
Allergan Pharmaceuticals International Limited
Patients Who Participated in an Intravitreal Brimo PS DDS® Study
1 trial -
Gatifloxacin 0.3% ophthalmic solution
Allergan Pharmaceuticals International Limited
Acute Bacterial Corneal Ulcers
1 trial -
botulinum toxin Type A
Allergan Pharmaceuticals International Limited
Benign Prostatic Hyperplasia
1 trial -
botulinum toxin type A
Allergan Pharmaceuticals International Limited
Cervical Dystonia
1 trial
Frequently asked questions
How many clinical projects does Allergan Pharmaceuticals International have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.